The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming

Cholangiocarcinoma (CCA) is a malignant cancer with an unknown etiology and an unfavorable prognosis. Most patients are diagnosed at an advanced stage, thus making it essential to find novel curative targets for CCA. Metabolic reprogramming of the tumor cells includes metabolic abnormalities in gluc...

Full description

Bibliographic Details
Main Authors:	Lei Xu, Lei Wang, Lixing Zhou, Robert Gregory Dorfman, Yida Pan, Dehua Tang, Yuming Wang, Yuyao Yin, Chengfei Jiang, Xiaoping Zou, Jianlin Wu, Mingming Zhang
Format:	Article
Language:	English
Published:	Elsevier 2019-05-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558618304652

Similar Items

SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
by: Lei Xu, et al.
Published: (2019-05-01)

Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
by: Mingming Zhang, et al.
Published: (2019-03-01)

A proteomic study of cMyc improvement of CHO culture
by: Dunn Michael J, et al.
Published: (2010-03-01)

Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism
by: Shan Huang, et al.
Published: (2017-12-01)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
by: Luca Simula, et al.
Published: (2018-12-01)

WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc
by: Chen Wu, et al.
Published: (2015-01-01)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
by: Hongwen Zhu, et al.
Published: (2023-06-01)

Adenylosuccinate lyase hydroxylation contributes to triple negative breast cancer via the activation of cMYC
by: Giada Zurlo, et al.
Published: (2020-03-01)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
by: Hany I. Sakr, et al.
Published: (2017-10-01)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
by: Jiang Bing-Hua, et al.
Published: (2010-05-01)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
by: Kuystermans Darrin, et al.
Published: (2009-09-01)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
by: Briollais Laurent, et al.
Published: (2007-06-01)

Adriamycin Induced Chemoresistance of Human TNBC MDA-MB-468 Cells Through Stat3-cMyc Signal Pathway
by: XU Jinyuan, et al.
Published: (2018-12-01)

Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
by: Mingming Zhang, et al.
Published: (2017-02-01)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
by: Song Y, et al.
Published: (2021-06-01)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
by: Houxiang Jiang, et al.
Published: (2023-05-01)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
by: Jasmine George, et al.
Published: (2023-03-01)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
by: Jasmine George, et al.
Published: (2021-11-01)

A versatile water soluble ball-type phthalocyanine as potential antiproliferative drug: the interaction with G-quadruplex formed from Tel 21 and cMYC
by: Efkan BAĞDA, et al.
Published: (2017-05-01)

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway
by: Xiaoxuan Zhao, et al.
Published: (2023-05-01)

BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
by: Esther J.Y. Kim, et al.
Published: (2018-02-01)

Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
by: Kishor Pant, et al.
Published: (2020-04-01)

The SIRT1-c-Myc axis in regulation of stem cells
by: Wei Fan, et al.
Published: (2023-07-01)

CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-α-Gabpa and stress-induced adaptive responses via NF-κB-cMYC.
by: Yun Kyoung Kang, et al.
Published: (2015-04-01)

Concomitant Classic Hodgkin Lymphoma of Lymph Node and cMYC-Positive Burkitt Leukemia/Lymphoma of the Bone Marrow Presented Concurrently at the Time of Presentation: A Rare Combination of Discordant Lymphomas
by: Dina S. Soliman, et al.
Published: (2016-08-01)

Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions
by: Caroline Henriques Garcia, et al.
Published: (2021-10-01)

KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
by: Jie Li, et al.
Published: (2018-08-01)

Correction: CAPER Is Vital for Energy and Redox Homeostasis by Integrating Glucose-Induced Mitochondrial Functions via ERR-α-Gabpa and Stress-Induced Adaptive Responses via NF-κB-cMYC.
by: PLOS Genetics Staff
Published: (2015-06-01)

Sirt6 regulates efficiency of mouse somatic reprogramming and maintenance of pluripotency
by: Peng Xu, et al.
Published: (2019-01-01)

SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc
by: Minghui Jiang, et al.
Published: (2024-03-01)

MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
by: Javier Prieto, et al.
Published: (2018-12-01)

Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma
by: Antonia Stamatiou, et al.
Published: (2021-12-01)

Expression of n-MYC, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin
by: Lydia Brandl, et al.
Published: (2018-09-01)

MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma
by: Kuo Jiang, et al.
Published: (2022-03-01)

Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
by: Go J. Yoshida, et al.
Published: (2020-05-01)

Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4
by: Ling Wang, et al.
Published: (2017-12-01)

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A
by: Nichelle C. Whitlock, et al.
Published: (2022-10-01)

SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
by: Jiyung Shin, et al.
Published: (2013-12-01)

SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
by: Jiyung Shin, et al.
Published: (2013-11-01)

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
by: Benluvankar Varghese, et al.
Published: (2023-09-01)